CA
NZ
UK
AU
IND
US
Coveo Solutions Inc. is a Canadian software company focused on artificial intelligence-powered search, recommendations and digital experience solutions. The company’s platform helps businesses improve customer interactions, enterprise knowledge access and digital commerce experiences through AI-driven relevance technology. The shares gained 2.40% on 28 September …
Shares of Abivax (NASDAQ:ABVX) ended Monday, September 28, 2026 higher by 6.36%, at $96.85. The clinical-stage biotech, listed in the United States and rooted in France, has drawn intense investor attention for its lead candidate in ulcerative colitis.
● Firefly Neuroscience (AIFF) closed at $1.69 on Monday, down 15.92% from $2.01, giving back part of Friday's surge.
Protagonist Therapeutics found itself in the spotlight on Friday after being featured in a Wall Street Journal story on the boom in peptide medicines, a theme that has captured investor imagination across biotech.
● Weiss Asset Management reported zero shares of Theravance Biopharma in a 13D/A filed September 25, 2026, the fourth amendment to its 2023 filing.
● VolitionRx issued 2,157,340 shares to Lind Global Asset Management XII LLC in two September 2026 tranches under a $2.4 million convertible note.
● Vistagen Therapeutics filed an 8-K disclosing it began using a new corporate presentation dated September 2026.
● Rocket One scheduled its 2026 annualShareholdermeeting for December 17, 2026, shifting from the prior August 2025 date.
● Rockwell Automation's ChiefRevenueOfficer Scott A. Genereux notified the company of his retirement on September 21, 2026.
● Legend Biotech's five-year CARTITUDE-2 Cohort A data showed 50% of 20 patients remained progression-free after one CARVYKTI infusion.
Please wait processing your request...